Loading bill…
Loading bill…
S. 2658 · Senate bill · 119th Congress
This bill requires applicants seeking approval of a drug or licensure of a biological product to submit certain information about relevant patents to both the Food and Drug Administration (FDA) and the U.S. Patent and Trademark Office (USPTO).
The text of this bill isn’t available to show here yet. Read it on Congress.gov (opens in a new tab)